Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer

Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer

Bibliographic Details
Main Authors: Wolff, A., Lazar, A., Bondarenko, I., Garin, A., Brincat, S., Chow, L., Sun, Y., Neskovic-Konstanovic, Z., Guimaraes, R., Fumoleau, P., Chan, Arlene, Hachemi, S., Strahs, A., Cincotta, M., Berkenblit, A., Krygowski, M., Kang, L.L., Moore, L., Hayes, D.
Format: Journal Article
Published: American Society of Clinical Oncology 2013
Online Access:http://hdl.handle.net/20.500.11937/9375

Internet

http://hdl.handle.net/20.500.11937/9375

Similar Items